Expired European patentEurope
Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
EP 1171144 B1 · Applicant: Sabinsa Corporation
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 2000 and granted February 14, 2007. A European patent lasts at most 20 years from filing, so its term ended April 7, 2020.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by October 7, 2025.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledApril 7, 2000
PublishedJanuary 16, 2002
GrantedFebruary 14, 2007
Term endedApril 7, 2020
Application numberEP 00921582
Classification (CPC)A61P43/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.